Evidence map›Paper›PMID 38149008›Full record

ArticleFrontiers in cellular and infection microbiology2023

Association of

Caleb M Ardizzone, Christopher M Taylor, Evelyn Toh, Rebecca A Lillis, Jacob H Elnaggar, John W Lammons, Patricia Dehon Mott, Emily L Duffy, Li Shen, Alison J Quayle

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Influence of cervicovaginal microbiota onMicrobial cell (Graz, Austria) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Caleb M ArdizzoneDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Christopher M TaylorDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Evelyn TohDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
Rebecca A LillisDepartment of Medicine, Section of Infectious Diseases, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Jacob H ElnaggarDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
John W LammonsDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Patricia Dehon MottDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Emily L DuffyDepartment of Medicine, Section of Infectious Diseases, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Li ShenDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Alison J QuayleDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Louisiana State University Health Sciences Center New Orleans · USIndiana University School of Medicine

Funding

Consequences of vaginal microbiota on IFNγ-mediated clearance of Chlamydia trachomatisR01AI118860 · NIAID · LSU HEALTH SCIENCES CENTER · PI AIYAR, ASHOK A, QUAYLE, ALISON J. · 2017 to 2020
$2.4M
NIAID NIH HHS R01 AI118860
6 · The paper itself

Abstract

Bacterial vaginosis (BV), a dysbiosis of the vaginal microbiota, is a common coinfection with

Indexed as

MicrobiotaVaginosis, BacterialChlamydia trachomatisFemaleHumansMetronidazoleRNA, Ribosomal, 16SVaginaMetronidazoleRNA, Ribosomal, 16Sbacterial vaginosisChlamydia trachomatisLactobacillusmetronidazolenatural clearancePrevotellavaginal microbiomewomen

Identifiers

PMID38149008
PMCPMC10750252
OpenAlexW4389613498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.